Medpace Holdings, Inc.

MEDPNASDAQHealthcare● Active

$456.86

+$2.61(+0.57%)

Market Cap$13.0B

P/E Ratio—

52W High$628.916

52W Low$293.2

Avg Volume375K

Open$454.25

Beta1.18

Insider Trades Ownership Employees

Medpace Holdings, Inc. (MEDP) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · MEDP · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Medpace Holdings, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

MEDP insider buying and selling by quarter

MEDP insider selling · MEDP insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

474K237K0

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · MEDP ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

MEDP executive sell shares · MEDP board member insider trading · MEDP insider trading SEC filing

Showing 54 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 28, 2026	EWALD STEPHEN P General Counsel & Corp. Secy.	Option	16,349	$138.87	$2.27M⚡	36,692	Form 4
May 28, 2026	EWALD STEPHEN P General Counsel & Corp. Secy.	Sale	16,349	$450.00	$7.36M⚡	20,343	Form 4
Apr 24, 2026	EWALD STEPHEN P General Counsel & Corp. Secy.	Option	3,500	$138.87	$486K	20,343	Form 4
Apr 24, 2026	Brady Kevin M. CFO & Treasurer	Option	7,000	$138.87	$972K	12,830	Form 4
Mar 31, 2026	McCarthy Cornelius P. III Director	Option	29	—	—	10,324	Form 4
Mar 31, 2026	Kraft Robert O. Director	Option	33	—	—	922	Form 4
Mar 31, 2026	Carley Brian T Director	Option	36	—	—	32,789	Form 4
Mar 18, 2026	BURWIG SUSAN E Exec. VP, Operations	Option	12,000	$166.73	$2.00M⚡	70,484	Form 4
Mar 17, 2026	GEIGER JESSE J President	Option	31,707	$138.87	$4.40M⚡	46,707	Form 4
Mar 17, 2026	GEIGER JESSE J President	Sale	31,707	$455.30	$14.44M⚡	15,000	Form 4
Feb 17, 2026	EWALD STEPHEN P General Counsel & Corp. Secy.	Option	3,500	$138.87	$486K	16,843	Form 4
Feb 13, 2026	Carley Brian T Director	Option	6,472	$54.99	$356K	32,753	Form 4
Feb 13, 2026	BURWIG SUSAN E Exec. VP, Operations	Option	10,984	$107.93	$1.19M⚡	58,484	Form 4
Dec 31, 2025	McCarthy Cornelius P. III Director	Option	49	—	—	10,295	Form 4
Dec 31, 2025	Kraft Robert O. Director	Option	56	—	—	889	Form 4
Dec 31, 2025	Carley Brian T Director	Option	62	—	—	26,281	Form 4
Dec 5, 2025	BURWIG SUSAN E Exec. VP, Operations	Option	10,000	$107.93	$1.08M⚡	47,500	Form 4
Dec 3, 2025	Troendle August J. CEO · Director	Sale	668	$590.69	$395K	646,184	Form 4
Dec 2, 2025	BURWIG SUSAN E Exec. VP, Operations	Option	10,000	$107.93	$1.08M⚡	37,500	Form 4
Dec 1, 2025	Troendle August J. CEO · Director	Sale	23,178	$593.25	$13.75M⚡	652,550	Form 4
Dec 2, 2025	Troendle August J. CEO · Director	Sale	5,698	$590.47	$3.36M⚡	646,852	Form 4
Nov 26, 2025	Troendle August J. CEO · Director	Sale	41,331	$606.88	$25.08M⚡	690,879	Form 4
Nov 28, 2025	Troendle August J. CEO · Director	Sale	15,151	$593.46	$8.99M⚡	675,728	Form 4
Nov 24, 2025	Troendle August J. CEO · Director	Sale	59,025	$607.78	$35.87M⚡	774,602	Form 4
Nov 25, 2025	Troendle August J. CEO · Director	Sale	42,392	$615.52	$26.09M⚡	732,210	Form 4

EWALD STEPHEN P

General Counsel & Corp. Secy.

Option

Date

May 28

16,349

Price

$138.87

Value

$2.27M ⚡

View Form 4 on SEC.gov

EWALD STEPHEN P

General Counsel & Corp. Secy.

Sale

Date

May 28

16,349

Price

$450.00

Value

$7.36M ⚡

View Form 4 on SEC.gov

EWALD STEPHEN P

General Counsel & Corp. Secy.

Option

Date

Apr 24

3,500

Price

$138.87

Value

$486K

View Form 4 on SEC.gov

Brady Kevin M.

CFO & Treasurer

Option

Date

Apr 24

7,000

Price

$138.87

Value

$972K

View Form 4 on SEC.gov

McCarthy Cornelius P. III

Director

Option

Date

Mar 31

Price

—

Value

—

View Form 4 on SEC.gov

Kraft Robert O.

Director

Option

Date

Mar 31

Price

—

Value

—

View Form 4 on SEC.gov

Carley Brian T

Director

Option

Date

Mar 31

Price

—

Value

—

View Form 4 on SEC.gov

BURWIG SUSAN E

Exec. VP, Operations

Option

Date

Mar 18

12,000

Price

$166.73

Value

$2.00M ⚡

View Form 4 on SEC.gov

GEIGER JESSE J

President

Option

Date

Mar 17

31,707

Price

$138.87

Value

$4.40M ⚡

View Form 4 on SEC.gov

GEIGER JESSE J

President

Sale

Date

Mar 17

31,707

Price

$455.30

Value

$14.44M ⚡

View Form 4 on SEC.gov

EWALD STEPHEN P

General Counsel & Corp. Secy.

Option

Date

Feb 17

3,500

Price

$138.87

Value

$486K

View Form 4 on SEC.gov

Carley Brian T

Director

Option

Date

Feb 13

6,472

Price

$54.99

Value

$356K

View Form 4 on SEC.gov

BURWIG SUSAN E

Exec. VP, Operations

Option

Date

Feb 13

10,984

Price

$107.93

Value

$1.19M ⚡

View Form 4 on SEC.gov

McCarthy Cornelius P. III

Director

Option

Date

Dec 31

Price

—

Value

—

View Form 4 on SEC.gov

Kraft Robert O.

Director

Option

Date

Dec 31

Price

—

Value

—

View Form 4 on SEC.gov

Carley Brian T

Director

Option

Date

Dec 31

Price

—

Value

—

View Form 4 on SEC.gov

BURWIG SUSAN E

Exec. VP, Operations

Option

Date

Dec 5

10,000

Price

$107.93

Value

$1.08M ⚡

View Form 4 on SEC.gov

Troendle August J.

CEO · Director

Sale

Date

Dec 3

668

Price

$590.69

Value

$395K

View Form 4 on SEC.gov

BURWIG SUSAN E

Exec. VP, Operations

Option

Date

Dec 2

10,000

Price

$107.93

Value

$1.08M ⚡

View Form 4 on SEC.gov

Troendle August J.

CEO · Director

Sale

Date

Dec 1

23,178

Price

$593.25

Value

$13.75M ⚡

View Form 4 on SEC.gov

Troendle August J.

CEO · Director

Sale

Date

Dec 2

5,698

Price

$590.47

Value

$3.36M ⚡

View Form 4 on SEC.gov

Troendle August J.

CEO · Director

Sale

Date

Nov 26

41,331

Price

$606.88

Value

$25.08M ⚡

View Form 4 on SEC.gov

Troendle August J.

CEO · Director

Sale

Date

Nov 28

15,151

Price

$593.46

Value

$8.99M ⚡

View Form 4 on SEC.gov

Troendle August J.

CEO · Director

Sale

Date

Nov 24

59,025

Price

$607.78

Value

$35.87M ⚡

View Form 4 on SEC.gov

Troendle August J.

CEO · Director

Sale

Date

Nov 25

42,392

Price

$615.52

Value

$26.09M ⚡

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About MEDP insider trading

MEDP insider trades

Medpace Holdings, Inc. (MEDP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Troendle August J. (CEO · Director), BURWIG SUSAN E (Exec. VP, Operations), GEIGER JESSE J (President). Over the past 12 months, 5 insiders have filed transactions with the SEC. MEDP insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Medpace Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

MEDP insider trading · 5 questions

The insiders of Medpace Holdings, Inc. (MEDP) include executives and directors such as Troendle August J. (CEO · Director), BURWIG SUSAN E (Exec. VP, Operations), GEIGER JESSE J (President), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

MEDP board member insider tradingwho are MEDP insidersMEDP insider rosterMedpace Holdings, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026